NEW PRODUCTS

MTS Systems Corp., Eden Prairie, has completed the development and installation of the motion system for the new Toyota Motor Corp. driving simulator at the Higashifuji Technical Center in Shizuoka, Japan. The simulator includes MTS motion mechanisms, controls and control software that provide scalable motion performance and response measurement.

MGI Pharma Inc., Bloomington, and its partner Helsinn Healthcare SA, a privately owned Swiss pharmaceutical group, said that a supplemental new drug application for Aloxi capsules for oral administration was accepted for filing by the U.S. Food and Drug Administration. Aloxi injection is approved by the FDA for the prevention of acute nausea and vomiting associated with initial and repeat courses of moderately and highly emetogenic cancer chemotherapy and for the prevention of delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

PERSONNEL MOVES

Mosaic Co., Plymouth, elected James Popowich to its board of directors. Popowich is president of the Canadian Institute of Mining, Metallurgy and Petroleum.

Synovis Life Technologies Inc., St. Paul, elected John Seaberg as an independent member of its board of directors. Seaberg is chairman and CEO of NeoChord Inc., an early-stage company developing cardiac surgery technology for minimally invasive mitral valve repair.

LEGAL MATTERS

Scanner Technologies Corp., Minneapolis, said that the U.S. Court of Appeals for the Federal Circuit has ordered a stay of a supplemental judgment entered Nov. 6 by the U.S. District Court for the Southern District of New York. The supplemental judgment awarded ICOS Vision Systems Corp. N.V. $3.4 million in fees and costs in a patent infringement suit initiated by Scanner Technologies in July 2000. Scanner filed an emergency motion Nov. 7 with the Appeals Court.